7Baggers
Quarterly
Annual
    Unit: USD2024-12-31 2024-09-30 
      
    		  
      cash flows from operating activities:
    		  
      net income
    		-33,121,000 -25,313,000 
      adjustments to reconcile net income to net cash from operating activities:
    		  
      depreciation and amortization
    		994,000 1,158,000 
      allowance for credit losses
    		  
      non-cash lease expense
    		616,000 618,000 
      unrealized (gain) loss on trading securities
    		  
      realized loss on trading securities
    		  
      accretion on marketable securities
    		  
      loss on disposal of fixed assets
    		  
      write-down of inventory
    		-5,620,000 824,000 
      goodwill impairment
    		  
      change in fair value of warrant liabilities
    		4,638,000 -121,000 
      change in fair value of contingent consideration
    		  
      change in fair value of stock consideration
    		  
      stock-based compensation
    		2,405,000 2,411,000 
      other
    		-1,000 1,000 
      changes in operating assets and liabilities:
    		  
      accounts receivable
    		-435,000 -424,000 
      inventory
    		5,967,000 123,000 
      prepaid expenses and other current assets
    		1,031,000 -1,431,000 
      operating lease right-of-use assets
    		  
      other assets
    		  
      accounts payable
    		301,000 194,000 
      accrued expenses and other current liabilities
    		2,678,000 1,861,000 
      other long-term liabilities
    		2,532,000 -869,000 
      operating lease liabilities
    		-3,414,000 9,000 
      net cash from operating activities
    		-22,881,000 -23,153,000 
      capex
    		-1,435,000 -975,000 
      free cash flows
    		-24,316,000 -24,128,000 
      cash flows from investing activities:
    		  
      purchases of property and equipment
    		-1,435,000 -975,000 
      internally developed software - capitalized costs
    		0 0 
      purchases of marketable securities
    		-107,390,000 -53,255,000 
      sales of marketable securities
    		  
      net cash from investing activities
    		-5,925,000 5,870,000 
      cash flows from financing activities:
    		  
      proceeds from exercise of stock options
    		934,000 2,000 
      proceeds from issuance of common stock from “at-the-market” offering, net of commissions and issuance costs
    		  
      proceeds from vesting of restricted stock
    		  
      deferred offering costs
    		 0 
      payment of contingent consideration - business acquisition
    		  
      payment of deferred consideration - business acquisition
    		  
      refund of issuance costs
    		  
      net cash from financing activities
    		35,794,000 2,000 
      effect of exchange rate changes on cash and cash equivalents
    		-15,000 -3,000 
      net increase in cash and cash equivalents
    		6,973,000 -17,284,000 
      cash and cash equivalents at beginning of period
    		0 0 
      cash and cash equivalents at end of period
    		6,973,000 -17,284,000 
      realized (gain) loss on trading securities
    		  
      amortization on marketable securities
    		 -2,194,000 
      gain on disposal of fixed assets
    		  
      sales and maturities of marketable securities
    		 60,100,000 
      refund of issuance costs from 2021 business combination
    		 0 
      supplemental disclosure of non-cash investing and financing activities:
    		  
      property and equipment purchased but not paid
    		 217,000 
      deferred offering costs payable
    		 0 
      (gain) loss on marketable securities
    		  
      (gain) loss on disposal of fixed assets
    		  
      supplemental disclosure of cash flow information:
    		  
      cash paid for income taxes
    		  
      other assets - related party
    		  
      business acquisition
    		  
      net proceeds from equity infusion from the business combination
    		  
      payment of notes payable
    		  
      stock issuance costs for series e convertible preferred stock
    		  
      principal payments under finance lease obligations
    		  
      cash received from exchange of research and development tax credits
    		  
      forgiveness of related party promissory notes
    		  
      noncash equity issuance - business acquisition
    		  
      noncash equity related warrants from the business combination
    		  
      conversion of the convertible preferred stock into class a and class b common stock
    		  
      noncash contingent consideration and holdbacks - business acquisition
    		  
      loss on marketable securities
    		  
      proceeds from issuance of series e convertible preferred stock
    		  
      proceeds from issuance of notes payable
    		  
      supplemental disclosure of noncash information:
    		  
      noncash acquisition of property and equipment
    		  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.